Aspire Biopharma Announces Positive Final Results for Sublingual Aspirin in Treating Heart Attacks

Aspire Biopharma announced positive final results from a clinical trial evaluating its investigational sublingual aspirin product for suspected acute ...
Home/KnloSights/Clinical Trial Updates/Aspire Biopharma Announces Positive Final Results for Sublingual Aspirin in Treating Heart Attacks